Burton Enright Welch’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.37M Sell
1,977
-554
-22% -$566K 0.28% 46
2026
Q1
$2.33M Sell
2,531
-84
-3% -$85.2K 0.32% 38
2025
Q4
$2.81M Sell
2,615
-93
-3% -$88.9K 0.4% 34
2025
Q3
$2.07M Sell
2,708
-205
-7% -$153K 0.31% 40
2025
Q2
$2.27M Buy
2,913
+23
+0.8% +$17.9K 0.39% 36
2025
Q1
$2.39M Sell
2,890
-742
-20% -$617K 0.49% 27
2024
Q4
$2.8M Buy
3,632
+3
+0.1% +$2.48K 0.59% 24
2024
Q3
$3.22M Hold
3,629
0.69% 22
2024
Q2
$3.29M Sell
3,629
-1,276
-26% -$1.02M 0.76% 20
2024
Q1
$3.82M Buy
4,905
+341
+7% +$243K 0.92% 18
2023
Q4
$2.66M Buy
4,564
+10
+0.2% +$5.84K 0.71% 19
2023
Q3
$2.45M Sell
4,554
-630
-12% -$325K 0.75% 17
2023
Q2
$2.43M Buy
5,184
+55
+1% +$23.1K 0.76% 18
2023
Q1
$1.76M Sell
5,129
-470
-8% -$159K 0.67% 22
2022
Q4
$2.05M Buy
+5,599
New +$1.99M 0.85% 20

Other funds holding LLY

Burton Enright Welch's LLY Position: Q2 2026 in Review

Burton Enright Welch reduced its Eli Lilly (LLY) stake by 22% in Q2 2026, selling an estimated $566K and leaving 1,977 shares worth $2.37M. The position accounts for 0.28% of the portfolio, ranked #46.

Burton Enright Welch first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.82M in Q1 2024. 1,912 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Burton Enright Welch held 1,977 shares of Eli Lilly worth $2.37M as of Q2 2026.
  • Burton Enright Welch sold 554 Eli Lilly shares in Q2 2026, an estimated $566K.
  • Eli Lilly made up 0.28% of Burton Enright Welch's portfolio in Q2 2026, its #46 holding.
  • Burton Enright Welch first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • Burton Enright Welch's Eli Lilly position peaked at $3.82M in Q1 2024.
  • 1,912 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Burton Enright Welch's 13F filing for Q2 2026, filed 17 Jul 2026.